Page 76

9:30–10:00 a.m.

Diagnosis and Assessment of Autism

Fred Volkmar, M.D., Professor of Child Psychiatry, Pediatrics, and Psychology, Yale Child Study Center

10:15–10:45 a.m.

Epidemiological Evidence on Rates of Autism and Time Trends

Eric Fombonne, M.D., FRCPsych, Reader in Epidemiological Child Psychiatry, Institute of Psychiatry, King's College London

10:45–11:00 a.m.

Trends in Students with Autism in IDEA Programs

Louis Danielson, Ph.D., Director of Research to Practice Division, Office of Special Education Programs, Department of Education

11:00–11:45 a.m.

Discussion Panel

Kathryn Carbone, M.D., Chief, Laboratory of Pediatric and Respiratory Viral Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration

Karin Nelson, M.D., Senior Investigator, Neuroepidemiology Branch, National Institute for Neurological Disorders and Stroke, National Institutes of Health

Ezra Susser, M.D., Head, Division of Epidemiology, Joseph L. Mailman School of Public Health, Columbia University

SESSION II: MMR AND AUTISM HYPOTHESIS

12:30–1:30 p.m.

Hypothesis and Data Linking MMR, Bowel Symptoms and Autism

Andrew Wakefield, M.D., Royal Free & University College Medical School, United Kingdom

Kenneth Aitken, Ph.D., Independent Consultant Child Clinical Neuropsychologist

1:30–2:00 p.m.

Overview of Epidemiological Studies Examining Potential Link Between MMR, Bowel Symptoms, and Autism

Michael Stoto, Ph.D., Chair, Department of Epidemiology and Biostatistics, George Washington University

2:00–2:30 p.m.

New Data and Research Findings Regarding a Potential Link Between MMR, Bowel Symptoms, and Autism



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement